Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy.

Trial Profile

Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2017

At a glance

  • Drugs Metreleptin (Primary)
  • Indications Lipodystrophy
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Sep 2017 Post-hoc analysis results (n=34) related to hepatomegaly were presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
    • 15 Sep 2017 According to a Novelion Therapeutics media release, post-hoc results were presented at the 10th International Meeting of Pediatric Endocrinology 2017.
    • 15 Sep 2017 Post-hoc results presented in a Novelion Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top